Background In the past decades, cancer enigmatical heterogeneity at distinct expression
levels could interpret disparities in therapeutic response and prognosis. It built hindrances to …

Over the past decade technological advances have enabled molecular profiling of human
cancers across distinct genomic domains and other “omes”. The availability of such multi …

Cancer causes significant morbidity and mortality worldwide, and is the area most targeted
in precision medicine. Recent development of high-throughput methods enables detailed …

The acceleration of large-scale sequencing and the progress in high-throughput
computational analyses, defined as omics, was a hallmark for the comprehension of the …

Cancer is a multifaceted and complex disease that results from the disruption of genetic,
epigenetic, and metabolic systems responsible for maintaining physiological conditions in …

Precision oncology involves identifying drugs that will effectively treat a tumor and then
prescribing an optimal clinical treatment regimen. However, most first-line chemotherapy …

The multitude of multi-omics data generated cost-effectively using advanced high-
throughput technologies has imposed challenging domain for research in Artificial …

Recent advances in omics technologies have led to unprecedented efforts characterizing
the molecular changes that underlie the development and progression of a wide array of …

Innovative multi-omics frameworks integrate diverse datasets from the same patients to
enhance our understanding of the molecular and clinical aspects of cancers. Advanced …

Multi-omics approaches are novel frameworks that integrate multiple omics datasets
generated from the same patients to better understand the molecular and clinical features of …